findmyKOL

Susheel Kodali, MD

Enriched profile

Avanessians Professor of Medicine; Director, Structural Heart and Valve Center · Columbia University Irving Medical Center

ORCIDNPI
Region🇺🇸 New York, NY · Northeast · United StatesSpecialtyInterventional CardiologyFocusCardiac Valve Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2016–2016

Susheel Kodali is Avanessians Professor of Medicine; Director, Structural Heart and Valve Center at Columbia University Irving Medical Center. OpenAlex indexes 769 publications with 61,381 citations (h-index 117); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Interventional Cardiology profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 27 Aug 2026

Susheel Kumar Kodali, MD, is Avanessians Professor of Medicine at Columbia University Irving Medical Center / NewYork-Presbyterian Hospital. The public record shows 769 publications with 61,381 citations (h-index 117), centered on Cardiac Valve Diseases and Treatments, Aortic Disease and Treatment Approaches, Infective Endocarditis Diagnosis and Management. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 15 companies, 1 NIH-funded awards (2016–2016).

  • Top research focus: Cardiac Valve Diseases and Treatments
  • 15 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Tricuspid Valve Insufficiency7 trialsCardiovascular Diseases5 trialsVascular Diseases5 trialsHeart Valve Diseases5 trialsAortic Valve Stenosis4 trialsConstriction, Pathologic4 trialsMitral Valve Insufficiency3 trialsHeart Failure1 trialAortic Valve Disease1 trial

Research focus

OpenAlex concept fingerprint
Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesInfective Endocarditis Diagnosis and ManagementCardiovascular Function and Risk FactorsCongenital Heart Disease Studies

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trialsIndustry payments3PublicationsLeqviogeneric · InclisiranClinical trialsIndustry payments2PublicationsAmvuttrageneric · VutrisiranClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials1Industry payments26Medtronic, Inc.Clinical trialsIndustry payments170Edwards Lifesciences CorporationClinical trialsIndustry payments86

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
769publications

Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.

61,381citations

Total citations across indexed works.

117h-index

Hirsch index (OpenAlex). i10-index 362.

Clinical & industry

trials, payments and federal funding
15clinical trials

Investigator role on registered studies.

View trials
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2016–2016

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2020)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    58.1%
    Potassium supplement58.1%
    Potassium Chloride100%
    Part D<11 patients
  • Blood & clotting

    41.9%
    P2Y12 inhibitor41.9%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)41.8% facility · 58.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 20162016 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Martin B. Leon473Rebecca T. Hahn310Vinod H. Thourani221

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/susheel-kodali-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/susheel-kodali-1632815

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • LinkedIn

    linkedin.com/in/susheel-kodali-7732968a

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    nyp.org/advances/article/cardiology/dr-susheel-kodali-perspective-on-newly-approved-transcatheter-approach-for-tricuspid-regurgitation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyp.org
  • Other

    tctmd.com/videos/late-breaking-clinical-trial-interview-sentinel-susheel-kodali-md.5783648635001

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.